Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Shinnihonseiyaku, Oct-Dec (1Q) Ordinary Profit Decreases by 1%
4931 Shinnihonseiyaku Co., Ltd. 【J-GAAP】
Earnings ReportShinnihonseiyaku Co., Ltd. <4931> [TSE Prime] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending September 2026 (October to December) was 1.54 billion yen, a 0.9% decrease compared to the same period last year. Progress toward the plan for the six months ending March (first half) of 2.55 billion yen was 60.4%, also surpassing the five-year average of 56.8%.
In the most recent three-month period, from October to December (1Q), the operating profit margin decreased from 14.6% in the same period last year to 14.3%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2023 | 9,941 | 1,167 | 1,171 | 783 | 36.4 | 56.2 | Feb 6, 2024 | J-GAAP |
| Oct - Dec, 2024 | 10,471 | 1,529 | 1,554 | 1,036 | 48.6 | 61.2 | Feb 7, 2025 | J-GAAP |
| Oct - Dec, 2025 | 10,645 | 1,518 | 1,540 | 1,061 | 50.2 | 60.4 | Feb 10, 2026 | J-GAAP |
| YoY | +1.7% | -0.7% | -0.9% | +2.4% | +3.4% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 20,282 | 2,533 | 2,540 | 935 | 44.0 | 0 | May 13, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 21,580 | 2,540 | 2,550 | 1,730 | 81.7 | 0 | Nov 11, 2025 | J-GAAP |
| YoY | +6.4% | +0.3% | +0.4% | +85.0% | +85.5% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2024 | 40,043 | 4,176 | 4,103 | 2,795 | 129.7 | 45 | Nov 12, 2024 | J-GAAP |
| Sep, 2025 | 41,140 | 4,782 | 4,887 | 2,554 | 120.5 | 52 | Nov 11, 2025 | J-GAAP |
| Sep, 2026 Guidance | 45,000 | 5,000 | 5,020 | 3,400 | 160.5 | 57 | Nov 11, 2025 | J-GAAP |
| YoY | +9.4% | +4.6% | +2.7% | +33.1% | +33.2% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 10,471 | 1,529 | 1,554 | 1,036 | 48.6 | 14.6 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 9,811 | 1,004 | 986 | -101 | -4.8 | 10.2 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 10,451 | 1,355 | 1,381 | 945 | 44.6 | 13.0 | Aug 5, 2025 | J-GAAP |
| Jul - Sep, 2025 | 10,407 | 894 | 966 | 674 | 31.8 | 8.6 | Nov 11, 2025 | J-GAAP |
| Oct - Dec, 2025 | 10,645 | 1,518 | 1,540 | 1,061 | 50.2 | 14.3 | Feb 10, 2026 | J-GAAP |
| YoY | +1.7% | -0.7% | -0.9% | +2.4% | +3.4% |
Related Articles
IMURAYA GROUP, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 19%, Exceeds Full-Year Plan
GMO GlobalSign, 11% Increase in Ordinary Profit, Record High for The First Time in Eight Years, Increased Previous Year's Dividend by 7.07 Yen, This Fiscal Year to Increase Dividend by 2.76 Yen
GMO Research&AI, 2.0 times Increase in Ordinary Profit, Record High for The First Time in Four Years, Dividend Raised by 4.69 Yen
Choei, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 10%, Oct-Dec Ordinary Profit Increases by 3.4 times
VIS, Oct-Dec (3Q) Ordinary Profit Increases by 20%
Sharp, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 16%
V Technology, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 3.9 times, Oct-Dec Ordinary Profit Increases by 2.5 times
Shiseido, Returning to Profitability This Year, Dividend Raised by 20 Yen
OTANI KOGYO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 30%, Exceeds Full-Year Plan
Kubota Pharma, Last Fiscal Year's Undisclosed Net Income to Narrow